VTRS

Viatris Inc

US StockNASDAQPharmaceutical Preparations

Research the business. Follow the filings.

Financial information from SEC disclosures, with reporting periods kept in context.

Revenue

14.3B USDAnnual · FY 2025

Operating income

-2.7B USDAnnual · FY 2025

Net income

0 USDAnnual · FY 2019

Total assets

37.2B USDAnnual · FY 2025

Equity

14.7B USDAnnual · FY 2025

Operating cash flow

2.3B USDAnnual · FY 2025

VTRS · Chart

Chart provided by TradingView. Loading the chart connects your browser to TradingView and sends necessary technical information such as your IP address, page URL, and displayed symbol.

Reported financial information

Revenue

USD

14.3B USD

Period data
PeriodValue
FY 202117.8B USD
FY 202216.2B USD
FY 202315.4B USD
FY 202414.7B USD
FY 202514.3B USD

Operating income

USD

-2.7B USD

Period data
PeriodValue
FY 2021-34M USD
FY 20221.6B USD
FY 2023766.2M USD
FY 202410.1M USD
FY 2025-2.7B USD

Net income

USD

0 USD

Period data
PeriodValue
FY 20190 USD

Total assets

USD

37.2B USD

Period data
PeriodValue
FY 202154.8B USD
FY 202250B USD
FY 202347.7B USD
FY 202441.5B USD
FY 202537.2B USD

Equity

USD

14.7B USD

Period data
PeriodValue
FY 202120.5B USD
FY 202221.1B USD
FY 202320.5B USD
FY 202418.6B USD
FY 202514.7B USD

Operating cash flow

USD

2.3B USD

Period data
PeriodValue
FY 20213B USD
FY 20223B USD
FY 20232.9B USD
FY 20242.3B USD
FY 20252.3B USD

Revenue growth

%

-3%

Period data
PeriodValue
FY 202150.7%
FY 2022-9%
FY 2023-5.1%
FY 2024-4.5%
FY 2025-3%

Operating income growth

%

Profit → Loss

Period data
PeriodValue
FY 2021Loss narrowed
FY 2022Loss → Profit
FY 2023-52.6%
FY 2024-98.7%
FY 2025Profit → Loss

Net income growth

%

No applicable data available

Period data
PeriodValue
FY 2019N/A

Operating margin

%

-18.7%

Period data
PeriodValue
FY 2021-0.2%
FY 202210%
FY 20235%
FY 20240.1%
FY 2025-18.7%

Net margin

%

No applicable data available

Period data
PeriodValue
FY 2019N/A

Return on assets

%

No applicable data available

Period data
PeriodValue
FY 2019N/A

Debt/Equity

x

1.53x

Period data
PeriodValue
FY 20211.68x
FY 20221.37x
FY 20231.33x
FY 20241.23x
FY 20251.53x